Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for PRGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 68.30M
March 31, 2026 -127.40M
December 31, 2025 148.60M
September 30, 2025 29.80M
June 30, 2025 56.70M
March 31, 2025 -91.50M
December 31, 2024 261.60M
September 30, 2024 15.10M
June 30, 2024 -18.90M
March 31, 2024 -26.50M
December 31, 2023 182.00M
September 30, 2023 92.70M
June 30, 2023 32.90M
March 31, 2023 -3.80M
December 31, 2022 169.80M
September 30, 2022 37.60M
June 30, 2022 -55.30M
March 31, 2022 58.80M
December 31, 2021 -76.50M
September 30, 2021 301.80M
June 30, 2021 -175.90M
March 31, 2021 -115.50M
December 31, 2020 43.20M
September 30, 2020 51.70M
June 30, 2020 231.80M
Date Value
March 31, 2020 105.30M
December 31, 2019 -20.80M
September 30, 2019 53.20M
June 30, 2019 30.20M
March 31, 2019 73.40M
December 31, 2018 145.70M
September 30, 2018 120.50M
June 30, 2018 62.40M
March 31, 2018 159.00M
December 31, 2017 178.70M
September 30, 2017 178.70M
June 30, 2017 76.00M
March 31, 2017 172.10M
December 31, 2016 184.60M
September 30, 2016 191.50M
June 30, 2016 108.80M
March 31, 2016 63.80M
December 31, 2015 -240.40M
September 30, 2015 15.40M
June 30, 2015 326.10M
March 31, 2015 148.30M
June 30, 2014 241.10M
March 31, 2014 138.30M
December 31, 2013 109.00M
September 30, 2013 33.50M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Avadel Pharmaceuticals Plc --
Jazz Pharmaceuticals Plc 397.60M
GH Research Plc -14.96M
Cosmo NV --
Viatris, Inc. 328.00M